Therapeutic Asset Ratings
6,308 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Cart-19 Cells
B-Cell Adult Acute Lymphocytic Leukemia
The First Affiliated Hospital of Soochow University
P1/2
CC
(47)
Cart30
Hodgkins Lymphoma
Chinese PLA General Hospital
P1/2
CC
(47)
Cbp-1019
Malignant Pancreatic Neoplasm
Coherent Biopharma (Hefei) Co., Ltd.
P1/2
CC
(47)
cd146/her2 car-t cells
Musculoskeletal System Cancer
Essen Biotech
P1/2
CC
(47)
cd19-cd34t metabolically programmed car transduced t-cells
B-Cell Non-Hodgkin Lymphoma
Medical University of South Carolina
P1/2
CC
(47)
cd22 car-t
B-Cell Acute Lymphoblastic Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
P1/2
CC
(47)
cd22 car-transduced t cells
B-Cell Neoplasm
Sheba Medical Center
P1/2
CC
(47)
cd22 car-transduced t cells
Follicular Lymphoma
Essen Biotech
P1/2
CC
(47)
cd22 car-transduced t cells
Mantle Cell Lymphoma
Essen Biotech
P1/2
CC
(47)
CD318-CAR-T cells
Pancreatic Ductal Adenocarcinoma
University Hospital Tuebingen
P1/2
CC
(47)
cd3/cd19 negative allogeneic hematopoietic stem cells
Inherited Susceptibility To Mycobacterial Diseases
Paul Szabolcs
P1/2
CC
(47)
cd45ra depleted leukocytes
Sickle Cell Disease
Paul Szabolcs
P1/2
CC
(47)
CD47/SIRPA-BLOCKING AGENT ALX148
Aggressive B-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer Center
P1/2
CC
(47)
CD47/SIRPA-BLOCKING AGENT ALX148
Indolent B-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer Center
P1/2
CC
(47)
Cephalotaxine 4-Methyl (2R)-2-Hydroxy-2-(4-Hydroxy-4-Methylpentyl)Butanedioate (Ester)
Hematopoietic And Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center
P1/2
CC
(47)
Cephalotaxine 4-Methyl (2R)-2-Hydroxy-2-(4-Hydroxy-4-Methylpentyl)Butanedioate (Ester)
Non-Hodgkin Lymphoma
First Affiliated Hospital of Zhejiang University
P1/2
CC
(47)
Cetuximab
Non-Small Cell Squamous Lung Carcinoma
Hummingbird Bioscience
P1/2
CC
(47)
Cetuximab
Biliary Tract Neoplasm
Eli Lilly and Company
P1/2
CC
(47)
Cetuximab
Peritoneal Carcinomatosis
M.D. Anderson Cancer Center
P1/2
CC
(47)
Cis-Diamminedichloroplatinum Ii
Biliary Tract Neoplasm
Eli Lilly and Company
P1/2
CC
(47)
Cis-Diamminedichloroplatinum Ii
Brain Glioblastoma
Zhongnan Hospital
P1/2
CC
(47)
Cish Inactivated Tumor Infiltrating Lymphocytes
Squamous Cell Lung Carcinoma
Intima Bioscience, Inc.
P1/2
CC
(47)
Cis-Retinoic Acid
Wilms Tumor
Centre Oscar Lambret
P1/2
CC
(47)
Cissus Quadrangularia
Obesity Disorder
University of Yaounde 1
P1/2
CC
(47)
Claudin18.2 Car-T Cells
Malignant Pancreatic Neoplasm
Essen Biotech
P1/2
CC
(47)
Showing 2251 to 2275 of 6,308 assets
Previous
Page 91 of 253
Next
